Medy-Tox Statistics
Total Valuation
Medy-Tox has a market cap or net worth of KRW 1.28 trillion. The enterprise value is 1.34 trillion.
Market Cap | 1.28T |
Enterprise Value | 1.34T |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
Earnings Date | Nov 14, 2024 |
Ex-Dividend Date | Sep 27, 2024 |
Share Statistics
Medy-Tox has 6.73 million shares outstanding. The number of shares has decreased by -49.34% in one year.
Shares Outstanding | 6.73M |
Shares Change (YoY) | -49.34% |
Shares Change (QoQ) | -17.85% |
Owned by Insiders (%) | 19.80% |
Owned by Institutions (%) | 9.62% |
Float | 4.96M |
Valuation Ratios
The trailing PE ratio is 283.21 and the forward PE ratio is 27.75.
PE Ratio | 283.21 |
Forward PE | 27.75 |
PS Ratio | 5.28 |
PB Ratio | 2.71 |
P/FCF Ratio | 440.86 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.54, with an EV/FCF ratio of 463.54.
EV / Earnings | 292.65 |
EV / Sales | 5.46 |
EV / EBITDA | 34.54 |
EV / EBIT | 65.11 |
EV / FCF | 463.54 |
Financial Position
The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.19.
Current Ratio | 1.28 |
Quick Ratio | 0.74 |
Debt / Equity | 0.19 |
Debt / EBITDA | 2.41 |
Debt / FCF | 31.32 |
Interest Coverage | 8.32 |
Financial Efficiency
Return on equity (ROE) is 1.14% and return on invested capital (ROIC) is 2.12%.
Return on Equity (ROE) | 1.14% |
Return on Assets (ROA) | 1.99% |
Return on Capital (ROIC) | 2.12% |
Revenue Per Employee | 350.29M |
Profits Per Employee | 6.54M |
Employee Count | 703 |
Asset Turnover | 0.40 |
Inventory Turnover | 1.53 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.60% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -15.60% |
50-Day Moving Average | 186,758.00 |
200-Day Moving Average | 170,849.50 |
Relative Strength Index (RSI) | 50.56 |
Average Volume (20 Days) | 77,507 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medy-Tox had revenue of KRW 246.25 billion and earned 4.59 billion in profits. Earnings per share was 670.87.
Revenue | 246.25B |
Gross Profit | 151.04B |
Operating Income | 19.41B |
Pretax Income | 12.86B |
Net Income | 4.59B |
EBITDA | 37.69B |
EBIT | 19.41B |
Earnings Per Share (EPS) | 670.87 |
Balance Sheet
The company has 30.23 billion in cash and 90.85 billion in debt, giving a net cash position of -60.63 billion or -9,006.52 per share.
Cash & Cash Equivalents | 30.23B |
Total Debt | 90.85B |
Net Cash | -60.63B |
Net Cash Per Share | -9,006.52 |
Equity (Book Value) | 477.74B |
Book Value Per Share | 70,206.93 |
Working Capital | 35.77B |
Cash Flow
In the last 12 months, operating cash flow was 10.56 billion and capital expenditures -7.66 billion, giving a free cash flow of 2.90 billion.
Operating Cash Flow | 10.56B |
Capital Expenditures | -7.66B |
Free Cash Flow | 2.90B |
FCF Per Share | 430.98 |
Margins
Gross margin is 61.33%, with operating and profit margins of 7.88% and 2.26%.
Gross Margin | 61.33% |
Operating Margin | 7.88% |
Pretax Margin | 5.22% |
Profit Margin | 2.26% |
EBITDA Margin | 15.30% |
EBIT Margin | 7.88% |
FCF Margin | 1.18% |
Dividends & Yields
This stock pays an annual dividend of 1,100.00, which amounts to a dividend yield of 0.59%.
Dividend Per Share | 1,100.00 |
Dividend Yield | 0.59% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 4 |
Payout Ratio | 151.21% |
Buyback Yield | 49.34% |
Shareholder Yield | 49.93% |
Earnings Yield | 0.35% |
FCF Yield | 0.23% |
Stock Splits
The last stock split was on December 28, 2022. It was a forward split with a ratio of 1.05.
Last Split Date | Dec 28, 2022 |
Split Type | Forward |
Split Ratio | 1.05 |
Scores
Medy-Tox has an Altman Z-Score of 7.28.
Altman Z-Score | 7.28 |
Piotroski F-Score | n/a |